{"title":"胸腔镜肺结节切除术后六子觉气功联合常规呼吸康复的疗效:随机临床试验","authors":"Ru-qi Xie , Xin Zhang","doi":"10.1016/j.rmed.2025.108349","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>To investigate the effect of Liuzijue Qigong on pulmonary function, respiratory distress and quality of life in patients after thoracoscopic pulmonary nodule resection.</div></div><div><h3>Methods</h3><div>Fifty-six patients who underwent pulmonary nodule resection in the Nanping First Hospital affiliated to Fujian Medical University from January 2023 to June 2024 were selected. According to the random number table method, they were divided into the intervention group (n = 20) and the control group (n = 20) with a ratio of 1:1. Patients began respiratory rehabilitation and Liuzijue training within 48 h postoperatively. The control group was given routine respiratory rehabilitation training, and the intervention group was given modified sitting Liuzijue training on the basis of routine respiratory rehabilitation training. The treatment time of the two groups was 1 week. The Tidal volume (VT), Forced expiratory volume in 1 s (FEV1), FEV1/FVC, Maximal voluntary ventilation (MVV), 36-Item Short Form Survey (SF-36), and St. George respiratory questionnaire (SGRQ) were compared between the two groups before and after treatment.</div></div><div><h3>Results</h3><div>After treatment, VT, FEV1 and MVV in the intervention group decreased less than those in the control group (<em>P</em> < 0.05). The SF-36 and SGRQ scores of the intervention group were significantly better than those of the control group (<em>P</em> < 0.05).</div></div><div><h3>Conclusions</h3><div>The results of this study show that Liuzijue Qigong as an auxiliary respiratory rehabilitation therapy can significantly reduce the pulmonary dysfunction of patients after thoracoscopic pulmonary nodule resection, and improve the ability of daily living and quality of life of patients. This study provides a new clinical treatment idea for enhanced recovery after surgery.</div><div>This trial was registered at the Chinese Clinical Trial Registry (<span><span>www.chictr.org.cn</span><svg><path></path></svg></span>) (trial registration number ChiCTR2400093856).</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"248 ","pages":"Article 108349"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of Liuzijue Qigong combined with conventional respiratory rehabilitation after thoracoscopic pulmonary nodule resection: A randomized clinical trial\",\"authors\":\"Ru-qi Xie , Xin Zhang\",\"doi\":\"10.1016/j.rmed.2025.108349\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>To investigate the effect of Liuzijue Qigong on pulmonary function, respiratory distress and quality of life in patients after thoracoscopic pulmonary nodule resection.</div></div><div><h3>Methods</h3><div>Fifty-six patients who underwent pulmonary nodule resection in the Nanping First Hospital affiliated to Fujian Medical University from January 2023 to June 2024 were selected. According to the random number table method, they were divided into the intervention group (n = 20) and the control group (n = 20) with a ratio of 1:1. Patients began respiratory rehabilitation and Liuzijue training within 48 h postoperatively. The control group was given routine respiratory rehabilitation training, and the intervention group was given modified sitting Liuzijue training on the basis of routine respiratory rehabilitation training. The treatment time of the two groups was 1 week. The Tidal volume (VT), Forced expiratory volume in 1 s (FEV1), FEV1/FVC, Maximal voluntary ventilation (MVV), 36-Item Short Form Survey (SF-36), and St. George respiratory questionnaire (SGRQ) were compared between the two groups before and after treatment.</div></div><div><h3>Results</h3><div>After treatment, VT, FEV1 and MVV in the intervention group decreased less than those in the control group (<em>P</em> < 0.05). The SF-36 and SGRQ scores of the intervention group were significantly better than those of the control group (<em>P</em> < 0.05).</div></div><div><h3>Conclusions</h3><div>The results of this study show that Liuzijue Qigong as an auxiliary respiratory rehabilitation therapy can significantly reduce the pulmonary dysfunction of patients after thoracoscopic pulmonary nodule resection, and improve the ability of daily living and quality of life of patients. This study provides a new clinical treatment idea for enhanced recovery after surgery.</div><div>This trial was registered at the Chinese Clinical Trial Registry (<span><span>www.chictr.org.cn</span><svg><path></path></svg></span>) (trial registration number ChiCTR2400093856).</div></div>\",\"PeriodicalId\":21057,\"journal\":{\"name\":\"Respiratory medicine\",\"volume\":\"248 \",\"pages\":\"Article 108349\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0954611125004123\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611125004123","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Efficacy of Liuzijue Qigong combined with conventional respiratory rehabilitation after thoracoscopic pulmonary nodule resection: A randomized clinical trial
Background
To investigate the effect of Liuzijue Qigong on pulmonary function, respiratory distress and quality of life in patients after thoracoscopic pulmonary nodule resection.
Methods
Fifty-six patients who underwent pulmonary nodule resection in the Nanping First Hospital affiliated to Fujian Medical University from January 2023 to June 2024 were selected. According to the random number table method, they were divided into the intervention group (n = 20) and the control group (n = 20) with a ratio of 1:1. Patients began respiratory rehabilitation and Liuzijue training within 48 h postoperatively. The control group was given routine respiratory rehabilitation training, and the intervention group was given modified sitting Liuzijue training on the basis of routine respiratory rehabilitation training. The treatment time of the two groups was 1 week. The Tidal volume (VT), Forced expiratory volume in 1 s (FEV1), FEV1/FVC, Maximal voluntary ventilation (MVV), 36-Item Short Form Survey (SF-36), and St. George respiratory questionnaire (SGRQ) were compared between the two groups before and after treatment.
Results
After treatment, VT, FEV1 and MVV in the intervention group decreased less than those in the control group (P < 0.05). The SF-36 and SGRQ scores of the intervention group were significantly better than those of the control group (P < 0.05).
Conclusions
The results of this study show that Liuzijue Qigong as an auxiliary respiratory rehabilitation therapy can significantly reduce the pulmonary dysfunction of patients after thoracoscopic pulmonary nodule resection, and improve the ability of daily living and quality of life of patients. This study provides a new clinical treatment idea for enhanced recovery after surgery.
This trial was registered at the Chinese Clinical Trial Registry (www.chictr.org.cn) (trial registration number ChiCTR2400093856).
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.